Rifampcin-induced Thrombocytopaenia Purpura

Indian J Chest Dis Allied Sci. 2016 Jul;58(3):189-190.

Abstract

We report the case of a 28-year-old resident doctor with no past history of having taken rifampicin, who presented with thrombocytoapaenic purpura occurring after the initiation of anti-tuberculosis therapy (isoniazid, rifampicin, pyrazinamide and ethambutol) for tubercular lymphadenopathy.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibiotics, Antitubercular / administration & dosage
  • Antibiotics, Antitubercular / adverse effects
  • Humans
  • Lymph Nodes / diagnostic imaging*
  • Male
  • Mediastinum*
  • Purpura, Thrombocytopenic / chemically induced
  • Purpura, Thrombocytopenic / diagnosis
  • Radiography, Thoracic / methods
  • Rifampin* / administration & dosage
  • Rifampin* / adverse effects
  • Treatment Outcome
  • Tuberculosis, Pulmonary* / diagnosis
  • Tuberculosis, Pulmonary* / drug therapy
  • Withholding Treatment

Substances

  • Antibiotics, Antitubercular
  • Rifampin